Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
Fragile X Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Scientific Presentations
Publications
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Nov 25, 2009
Dr John Holaday joins Neuren Board
Nov 18, 2009
Appendix 3B (notes)
Nov 18, 2009
Appendix 3B (options)
Nov 18, 2009
Notice under section 708A(5)(e) of the Corporations Act
Nov 18, 2009
Neuren Arranges up to AU$7.8m in New Funding
Nov 18, 2009
Appendix 3B (shares)
Nov 18, 2009
Reinstatement to Official Quotation
Nov 16, 2009
Suspension from Official Quotation
Nov 12, 2009
Trading Halt
Oct 30, 2009
Appendix 4C - quarterly
Previous
1
2
3
4
5
6
Next